From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Exclusive: Administrator files new damning report into Julie Meyer's Ariadne Capital Limited

By Tom Winnifrith | Wednesday 25 July 2018


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


It is not yet up at Companies House but I have obtained a copy of the latest report by Leonard Curtis into the administration of Ariadne Capital Limited (ACL), the flagship company of Julie "Lingerie on Expenses" Meyer MBE. I reproduce it in full below and it will make very uncomfortable reading indeed for Ms Meyer.

You will note that investigations continue into both the transfer of assets out of ACL into Julie's Maltese company ACGL shortly before ACL went tits up. and also into the sale of ECG by Ariadne to Julie's joke ACE Fund in 2016 which Ariadne booked as a profit but ACE never paid for. You will also note that a report has gone into the Insolvency Service which may lead to Ms Meyer being banned as a company director for up to 15 years. Bring it on!

This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 20:23:16